Narrow Results

Common Epilepsy Gene Discovered.

Peptide Found May Eliminate Anthrax.

Strong Demand for AEDs in Japan.

Fast Antibodies Peptide Mapping Solution from Agilent.

Thomson to Acquire Information Holdings.

Agilent Technologies licenses SureFISH to BioDiscovery.

Bionomics acquires US-based cancer stem cell company Eclipse Therapeutics.

AB SCIEX announces Biologics Initiative.

Phylogica licences skin-repair peptide to Le Métier De Beauté for cosmetic market.

Brooks' Single-use REMP tubes support optimization of automated serum and plasma storage

Genetic Technologies announces key managerial appointment Mark Ostrowski to head-up US sales for BREVAGen™.

BioScience Managers banks on growth of anti-infectives market.

Rodin Therapeutics applies insights of epigenetics to neurological disorders.

LBT Innovations finalizes joint venture to drive global production of world-class automated diagnostics technology.

Phylogica expands collaborations with Janssen for peptide-drug conjugates.

Immune Design and Medicago announce license agreement and collaboration to develop novel adjuvanted pandemic influenza vaccines.

Bayat Foundation inaugurates new pediatric critical care facility at Indira Gandhi Hospital in Kabul.

The International Peptide Symposium Held in Singapore for the First Time.

Inspirations from 2015 FWIS L'Oréal Winners.

Emerging Opportunities in Myanmar's Diagnostic Imaging and In Vitro Diagnostics.

High-Throughput Sequencing on a Next Generation Sequencer to Identify Specific Binders from a Phage Library

Antibody Solution Viscosity and Intermolecular Interactions: Considerations for Development of Highly Concentrated Formulations

Display of Membrane Proteins on a Viral Envelope for Antibody Generation

Sequence and Structural Determinants of Antigen Binding in Antibody CDR Loops

Enhancement of the Stability of Single Chain Fv Molecules with the Amino Acid Substitutions Predicted by High-Performance Computer

Thermal Stability of Camelid Single Domain VHH Antibody

In addition to controlling the structure of multi-chromophoric arrays, monitoring the spatial orientation of the chromophores in artificial light harvesting devices is a challenge of growing interest. We report in this article our recent advances in this field. It is expected that a better understanding of the physicochemical properties of rigid cofacial porphyrinic tweezers and an identification of the factors governing them will be crucial for the design and the elaboration of new nano-molecules endowed with original properties. Extended multi-porphyrinic architectures, polypeptides bearing pendant porphyrins have been synthesized as linear devices, and a star-like pentaporphyrin as an arborescent array. The structure and the original conformation of the latter confer to this system an unusual duality in its physicochemical properties.

In this paper we now report our ongoing progress in the preparation of artificial photosynthetic systems through the preparation of light harvesting multi-porphyrins. A tetramer, constituted of a central dipeptide functionalized by two free-base porphyrins and surrounded by one amino-acid bearing a pendant Zn(II) porphyrin on each side, has been chosen. The optical and photophysical properties of this tetramer have been studied by absorption and fluorescence spectroscopy. In addition, the energy transfer phenomenon has been studied and monitored by femtosecond time-resolved fluorescence. Our results indicate that the excited state dynamics redounding in the excitation being localized in the inner free-base porphyrins takes place in the time scale of approximately 1 ps.

We report herein the binding studies of three bis-porphyrinic tweezers bearing nucleosidic linkers and a bis-porphyrinic dipeptide with two bidentate bases of different size, DABCO and 4,4' -bipyridine. In the nucleosidic series, the nucleoside confers, for two dimers out of three, sufficient preorganization to the dimers to enhance the association constants, documenting the fact that rigid dimers are not necessary for preorganization, and opening up new routes to the faster synthesis of flexible tweezers capable of complexing guests with a high association constant. Comparison of these results with those obtained for rigid tweezers shows a better efficiency of the flexible nucleosidic dimers. We thus document the fact that the choice of rigid spacers is not the only way to pre-organize bis-porphyrins, and that some well-chosen nucleosidic linkers offer an interesting option for the synthesis of such devices.

meso-Tris(3,5-di-tert-butylphenyl)porphyrin (P-H) is bonded with L-phenylalanine (H-Phe-OH) directly at the unsubstituted meso-position of the former and the p-position of phenyl group of the latter to afford chiral porphyrin-amino acid conjugate H-Phe(p-P)-OH. The N-(9-fluorenyl)-methyloxycarbonyl compound, Fmoc-Phe(p-P)-OH, was synthesized without any loss of enantiomeric purity (based on chiral HPLC analysis) from commercially available L-tyrosine and was useful for preparation of the peptides in both liquid and solid phases. Other meso-tetraarylporphyrins possessing multi-amino acid moieties are reported, as well as achiral porphyrin-amino acids readily prepared and their dipeptidyl porphyrin dyads.

Five amphiphilic protoporphyrin IX-peptide conjugates bearing the sequences ATWLPPR, AAhexPQRRSARLSA and cERGDPhe conjugated via the propionic side chains, were synthesized and evaluated in vitro using two cell lines: human carcinoma HEp2 and human leukemia HL-60. All conjugates were found to have low dark- and photo-toxicities in both cell lines, and 3 to 10-fold higher accumulation was observed within HL-60 vs. HEp2 cells, depending on the nature of the peptide sequence. The preferential subcellular sites of localization for all conjugates were found to be the lysosomes in HEp2 cells, and the mitochondria in HL-60 cells, suggesting different mechanisms of cellular internalization.

The synthesis and in vitro evaluation of four mesoporphyrin IX-peptide conjugates designed to target EGFR, over-expressed in colorectal and other cancers, are reported. Two peptides with known affinity for EGFR, LARLLT (1) and GYHWYGYTPQNVI (2), were conjugated to mesoporphyrin IX (MPIX, 3) via one or both the propionic side chains, directly (4, 5) or with a triethylene glycol spacer (7, 8). The conjugates were characterized using NMR, MS, CD, SPR, UV-vis and fluorescence spectroscopies. Energy minimization and molecular dynamics suggest different conformations for the conjugates. SPR studies show that conjugate 4, bearing two LARLLT with no PEG spacers, has the greatest affinity for binding to EGFR, followed by conjugate 7with two PEG and two LARLLT sequences. Molecular modeling and docking studies suggest that both conjugates 4 and 7 can bind to monomer and dimer EGFR in open and closed conformations. The cytotoxicity and cellular targeting ability of the conjugates were investigated in human HEp2 cells over-expressing EGFR. All conjugates showed low dark- and photo-toxicities. The cellular uptake was highest for conjugates 4 and 8 and lowest for 7 bearing two LARLLT linked via PEG groups, likely due to decreased hydrophobicity. Among the conjugates investigated, 4 is the most efficient EGFR-targeting agent, and therefore the most promising for the detection of cancers that over-express EGFR.

This short review highlights the author’s group research on modified vitamin B${}_{12}$ derivatives with a peptide backbone as (1) inhibitors of B${}_{12}$-dependent enzymes and as (2) models of cofactor B${}_{12}$-protein complexes.

Porphyrin-peptide conjugates have a breadth of potential applications, including use in photodynamic therapy, boron neutron capture therapy, as fluorescence imaging tags for tracking subcellular localization, as magnetic resonance imaging (MRI) positive-contrast reagents and as biomimetic catalysts. Here, we have explored three general routes to porphyrin-peptide conjugates using the Cu(I)-catalyzed Huisgen-Medal-Sharpless 1,3-dipolar cycloaddition of peptide-containing azides with a terminal alkyne-containing porphyrin, thereby generating porphyrin-peptide conjugates (PPCs) comprised of a cationic porphyrin coupled to short antimicrobial peptides. In addition to characterizing the PPCs using a variety of spectroscopic (UV-vis, ${}^{\mathrm{\text{1}}}$H- and ${}^{\mathrm{\text{13}}}$C-NMR) and mass spectrometric methods, we evaluated their efficacy as photosensitizers for the in vitro photodynamic inactivation of Mycobacterium smegmatis as a model for the pathogen Mycobacterium tuberculosis. Difficulties that needed to be overcome for the efficient synthesis of PPCs were the limited solubility of the quaternized pyridyl porphyrin in common solvents, undesired (de)metallation and transmetallation, and chromatographic purification. Photodynamic inactivation studies of a small library of PPCs against Mycobacterium smegmatis confirmed our hypothesis that the porphyrin-based photosensitizer maintains its ability to efficiently inactivate bacteria when conjugated to a small peptide by upwards of 5–6 log units (99.999$+$%) using white light illumination (400–700 nm, 60 mW/cm${}^{\mathrm{\text{2}}}$, 30 min). Further, hemolysis assays revealed the lack of toxicity of the PPCs against sheep blood at concentrations employed for in vitro photodynamic inactivation. Taken together, the results demonstrated the ability of PPCs to maintain their antimicrobial photodynamic inactivation efficacy when possessing a short cationic peptides for enabling the potential targeting of pathogens in vivo.

The synthesis and biological studies of BODIPY-GPR peptide conjugate (BD-2) are reported. As compared to the parent BODIPY (BD-1), the peptide linked BD-2showed blue shifted absorption and emission with excellent Stokes shift of 201 nm. Molecular docking studies on EGFR protein kinase indicated very efficient binding affinity of BD-2 as compared to the standard drug (Erlotinib). The cell viability experiments of BD-2on normal (HEK293T) and lung cancer (A549) cell lines indicated 85–95% viability. Bioimaging studies showed that, BD-2was able to penetrate the lung cancer cell line.

Helices are ubiquitous in art and nature. Independent of their pitch and sense of rotation (handedness), helices in sculpture, painting, architecture, scientific illustrations, conference announcements, logos, and advertising are eye-catching and aesthetically pleasing. Helices can turn either clockwise (right-handed helix) or anti-clockwise (left-handed helix). The $\alpha$-helix formed by l-amino acids and the double helices formed by $\beta$-d-2^′-deoxyribonucleic acid (A- and B-form DNA) and $\beta$-d-ribonucleic acid (A-form RNA) are all right-handed. Artistic license provides the freedom to create helices of any shape and sense; indeed, many helical sculptures do not follow the natural convention observed in proteins and DNA. What is more surprising, given that models of the $\alpha$-helix and the DNA double helix were published over 70 years ago, is how common left-handed DNA double helices are in the context of scientific papers and books as well as in popular science writing and reporting. In all cases except for left-handed Z-DNA, the use of left-handed helices in scientific illustrations or models is incorrect. Here, we revisit the helix types adopted by peptides, DNA, and RNA, and review examples of right and wrong helical models in science, art, and elsewhere.

Porphyrin-peptide conjugates have a breadth of potential applications, including use in photodynamic therapy, boron neutron capture therapy, as fluorescence imaging tags for tracking subcellular localization, as magnetic resonance imaging (MRI) positive-contrast reagents and as biomimetic catalysts. Here, we have explored three general routes to porphyrin-peptide conjugates using the Cu(I)-catalyzed Huisgen-Medal-Sharpless 1,3-dipolar cycloaddition of peptide-containing azides with a terminal alkyne-containing porphyrin, thereby generating porphyrin-peptide conjugates (PPCs) comprised of a cationic porphyrin coupled to short antimicrobial peptides. In addition to characterizing the PPCs using a variety of spectroscopic (UV-vis, ¹H- and ¹³C-NMR) and mass spectrometric methods, we evaluated their efficacy as photosensitizers for the in vitro photodynamic inactivation of Mycobacterium smegmatis as a model for the pathogen Mycobacterium tuberculosis. Difficulties that needed to be overcome for the efficient synthesis of PPCs were the limited solubility of the quaternized pyridyl porphyrin in common solvents, undesired (de)metallation and transmetallation, and chromatographic purification. Photodynamic inactivation studies of a small library of PPCs against Mycobacterium smegmatis confirmed our hypothesis that the porphyrin-based photosensitizer maintains its ability to efficiently inactivate bacteria when conjugated to a small peptide by upwards of 5–6 log units (99.999+%) using white light illumination (400–700 nm, 60 mW/cm², 30 min). Further, hemolysis assays revealed the lack of toxicity of the PPCs against sheep blood at concentrations employed for in vitro photodynamic inactivation. Taken together, the results demonstrated the ability of PPCs to maintain their antimicrobial photodynamic inactivation efficacy when possessing a short cationic peptides for enabling the potential targeting of pathogens in vivo.